Spire Wealth Management Reviva Pharmaceuticals Holdings, Inc. Transaction History
Spire Wealth Management
- $3.13 Billion
- Q4 2024
A detailed history of Spire Wealth Management transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Spire Wealth Management holds 1,200 shares of RVPH stock, worth $2,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,200Holding current value
$2,400% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RVPH
# of Institutions
45Shares Held
10MCall Options Held
133KPut Options Held
43.9K-
Armistice Capital, LLC New York, NY3.19MShares$6.37 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.83MShares$3.67 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.52MShares$3.03 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$2.05 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA685KShares$1.37 Million0.01% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $40.9M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...